History
| May 2009 |
Established as an anti-cancer drug development company |
| August 2012 |
Started engaging in activities as a CRO / CDMO in Taiwan and the United States Exclusive agency contract with MBI |
| September 2016 | Commenced Licensing business |
| July 2018 | Served as Secretariat of Japan Pharmaceutical Licensing Association (volunteer) |
| May 2020 | Entered into Licensing business alliance with ADM Korea Inc. |
